The study demonstrates detailed kinetics of N-ribosidic bond cleavage in human enzyme HsDNPH1, suggesting a significant transition state.
The human enzyme 2′-deoxynucleoside 5′-phosphate N-hydrolase 1 (HsDNPH1) catalyses the N-ribosidic bond hydrolysis of the noncanonical nucleotide 5-hydroxymethyl-2′-deoxyuridine 5′-monophosphate (5hmdUMP), producing 5-hydroxymethyluracil and 2-deoxyribose 5-phosphate, preventing 5hmdUMP incorporation into DNA. This reaction is unusual for a nucleoside/nucleotide N-hydrolase as it proceeds by a double-displacement mechanism whereby Glu104 nucleophilically attacks 5hmdUMP to form a covalent 5-phospho-2-deoxyribosylated enzyme intermediate, which is subsequently hydrolysed. Here we used site-directed mutagenesis and UV-VIS differential spectroscopy to show a shift in the 5hmdUMP absorbance spectrum upon binding to HsDNPH1 before N-ribosidic bond cleavage. This spectral shift can be monitored independently in different wavelengths to characterise the kinetics of HsDNPH1-5hmdUMP binary complex formation. The one-step binding mechanism produces a calculated equilibrium dissociation constant in agreement with that obtained by isothermal titration calorimetry. Pre-steady-state kinetics under multiple-turnover conditions revealed absence of a burst of substrate consumption at a wavelength where binding does not lead to change in absorbance. This indicates steps after N-ribosidic bond cleavage are fast. Single-turnover kinetics, where the signal comes solely from the first half-reaction, indicate N-ribosidic bond cleavage in the first half-reaction is determining for kcat. Linear free energy relationships between leaving groups with increased pKa and kcat/KM suggest a late transition state with significant negative charge accumulation in the leaving group during N-ribosidic bond cleavage. These results were complemented by on-enzyme QM/MM calculations of the first half-reaction to reveal an anionic leaving group in an SN2-like transition state with C1′–N1 bond cleavage more advanced than C1–O bond formation with Glu104.
No takes yet. Share an insight, caveat, or question.
Carberry et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: